By Toni Clarke
BOSTON (Reuters) - Biotechnology company Millennium Pharmaceuticals Inc MLNM.O said on Thursday that it won't be as aggressive as some of its rivals when it comes to bidding for experimental new drugs.
At a time of massive price inflation for promising new products, Millennium, which makes cancer drug Velcade, says it has a mandate from its shareholders to do deals if it can, but not at any price.
"One of our strategies is to look outside to accelerate growth," said Deborah Dunsire, Millennium's chief executive, at the Reuters Health Summit in New York. "But our larger shareholders want us to stay religiously focused on being able to return value after we've paid for the assets."
Last year, Millennium entered a bidding war with biotechnology company Genzyme Corp (GENZ.O: Quote, Profile, Research, Stock Buzz) for AnorMED Inc of Canada. Millennium dropped out of the bidding and Genzyme paid $580 million for an experimental blood cancer product that some analysts did not consider worth the price.
Millennium, while looking for potential acquisitions, is mainly focused on its pipeline of experimental products and on partnerships for some of them.
Dunsire said the company has talked to several potential partners about MLN1202, its experimental antibody designed to reduce C-reactive protein, which evidence suggests may be associated with a greater risk atherosclerosis, a leading cause of coronary artery disease.
So far there is no proof that elevated C-reactive protein directly contributes to an increased risk of heart disease, which means the U.S. Food and Drug Administration would not approve it just because it reduces the protein, Dunsire said.
But other companies involved in developing drugs for cardiovascular disease could find it a very valuable tool and potentially a product in its own right. Continued...
© Thomson Reuters 2008. All rights reserved.
| Global Environment | Oct 06 - 8, 2008 | Energy |
| Autos II | Sep 30 - Oct 01, 2008 | Hotels/Casinos |
| Restructuring | Sep 22 - 26, 2008 | Financial Services/Exchanges |
| Autos | Sep 15 - 17, 2008 | Autos |
| Russia Investment | Sep 08 - 9, 2008 | Country Summits |
